Hyposensitizing therapy with standard antigenic extracts

An important source of thimerosal sensitization

Antonella Tosti, L. Guerra, F. Bardazzi

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The frequency of thimerosal sensitization was determined in 5 groups of subjects: military recruits; healthy subjects; patients with asthma or rhinitis undergoing hyposensitizing therapy with thimerosal-preserved antigenic extracts; patients with allergic contact dermatitis; patient with allergic contact conjunctivitis. Our patients with allergic contact dermatitis have a higher incidence of positive patch tests to thimerosal than healthy subjects. The source of thimerosal sensitization in this group remains obscure, their history of exposure to this or to other mercury derivatives being comparable to that of the healthy population. Patients with allergic contact conjunctivitis and patients receiving immunotherapy for asthma or rhinitis present a significantly higher frequency of thimerosal sensitization than the other groups, indicating that ophthalmic solutions and thimerosal-preserved allergen extracts are an important source of thimerosal sensitization. The clinical relevance of thimerosal sensitization was definitively established only in patients with allergic contact conjunctivitis, even though patients receiving immunotherapy frequently presented local reactions at the site of allergen inoculation.

Original languageEnglish
Pages (from-to)173-176
Number of pages4
JournalContact Dermatitis
Volume20
Issue number3
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Thimerosal
Allergic Conjunctivitis
Dermatitis
Allergic Contact Dermatitis
Therapeutics
Rhinitis
Immunotherapy
Allergens
Healthy Volunteers
Asthma
Patch Tests
Ophthalmic Solutions
Mercury
Derivatives

ASJC Scopus subject areas

  • Immunology
  • Dermatology
  • Toxicology

Cite this

Hyposensitizing therapy with standard antigenic extracts : An important source of thimerosal sensitization. / Tosti, Antonella; Guerra, L.; Bardazzi, F.

In: Contact Dermatitis, Vol. 20, No. 3, 01.01.1989, p. 173-176.

Research output: Contribution to journalArticle

@article{2eca58402da843609f0894564753cd87,
title = "Hyposensitizing therapy with standard antigenic extracts: An important source of thimerosal sensitization",
abstract = "The frequency of thimerosal sensitization was determined in 5 groups of subjects: military recruits; healthy subjects; patients with asthma or rhinitis undergoing hyposensitizing therapy with thimerosal-preserved antigenic extracts; patients with allergic contact dermatitis; patient with allergic contact conjunctivitis. Our patients with allergic contact dermatitis have a higher incidence of positive patch tests to thimerosal than healthy subjects. The source of thimerosal sensitization in this group remains obscure, their history of exposure to this or to other mercury derivatives being comparable to that of the healthy population. Patients with allergic contact conjunctivitis and patients receiving immunotherapy for asthma or rhinitis present a significantly higher frequency of thimerosal sensitization than the other groups, indicating that ophthalmic solutions and thimerosal-preserved allergen extracts are an important source of thimerosal sensitization. The clinical relevance of thimerosal sensitization was definitively established only in patients with allergic contact conjunctivitis, even though patients receiving immunotherapy frequently presented local reactions at the site of allergen inoculation.",
author = "Antonella Tosti and L. Guerra and F. Bardazzi",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "20",
pages = "173--176",
journal = "Contact Dermatitis",
issn = "0105-1873",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Hyposensitizing therapy with standard antigenic extracts

T2 - An important source of thimerosal sensitization

AU - Tosti, Antonella

AU - Guerra, L.

AU - Bardazzi, F.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The frequency of thimerosal sensitization was determined in 5 groups of subjects: military recruits; healthy subjects; patients with asthma or rhinitis undergoing hyposensitizing therapy with thimerosal-preserved antigenic extracts; patients with allergic contact dermatitis; patient with allergic contact conjunctivitis. Our patients with allergic contact dermatitis have a higher incidence of positive patch tests to thimerosal than healthy subjects. The source of thimerosal sensitization in this group remains obscure, their history of exposure to this or to other mercury derivatives being comparable to that of the healthy population. Patients with allergic contact conjunctivitis and patients receiving immunotherapy for asthma or rhinitis present a significantly higher frequency of thimerosal sensitization than the other groups, indicating that ophthalmic solutions and thimerosal-preserved allergen extracts are an important source of thimerosal sensitization. The clinical relevance of thimerosal sensitization was definitively established only in patients with allergic contact conjunctivitis, even though patients receiving immunotherapy frequently presented local reactions at the site of allergen inoculation.

AB - The frequency of thimerosal sensitization was determined in 5 groups of subjects: military recruits; healthy subjects; patients with asthma or rhinitis undergoing hyposensitizing therapy with thimerosal-preserved antigenic extracts; patients with allergic contact dermatitis; patient with allergic contact conjunctivitis. Our patients with allergic contact dermatitis have a higher incidence of positive patch tests to thimerosal than healthy subjects. The source of thimerosal sensitization in this group remains obscure, their history of exposure to this or to other mercury derivatives being comparable to that of the healthy population. Patients with allergic contact conjunctivitis and patients receiving immunotherapy for asthma or rhinitis present a significantly higher frequency of thimerosal sensitization than the other groups, indicating that ophthalmic solutions and thimerosal-preserved allergen extracts are an important source of thimerosal sensitization. The clinical relevance of thimerosal sensitization was definitively established only in patients with allergic contact conjunctivitis, even though patients receiving immunotherapy frequently presented local reactions at the site of allergen inoculation.

UR - http://www.scopus.com/inward/record.url?scp=0024520364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024520364&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 173

EP - 176

JO - Contact Dermatitis

JF - Contact Dermatitis

SN - 0105-1873

IS - 3

ER -